Blueprint Medicines Corp
NASDAQ:BPMC

Watchlist Manager
Blueprint Medicines Corp Logo
Blueprint Medicines Corp
NASDAQ:BPMC
Watchlist
Price: 129.46 USD 0.14%
Market Cap: 8.4B USD

Wall Street
Price Targets

BPMC Price Targets Summary
Blueprint Medicines Corp

There are no price targets for BPMC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Blueprint Medicines Corp Competitors:
Price Targets
2480
Beijing Luzhu Biotechnology Co Ltd
37% Upside
TNG
Transgene SA
76% Upside
688278
Xiamen Amoytop Biotech Co Ltd
18% Upside
ADCT
ADC Therapeutics SA
102% Upside
688177
Bio-Thera Solutions Ltd
58% Upside
CNTB
Connect Biopharma Holdings Ltd
250% Upside
LTRN
Lantern Pharma Inc.
530% Upside

Revenue
Forecast

Revenue Estimate
Blueprint Medicines Corp

The compound annual growth rate of Blueprint Medicines Corp's revenue for the next 3 years is 34%.

N/A
Past Growth
34%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Blueprint Medicines Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Blueprint Medicines Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BPMC's stock price target?
Not Available

BPMC doesn't have any price targets made by Wall Street professionals.

What is Blueprint Medicines Corp's Revenue forecast?
Projected CAGR
34%

The compound annual growth rate of Blueprint Medicines Corp's revenue for the next 3 years is 34%.

Back to Top